211 filings
Page 10 of 11
8-K
kqx36pa
3 Jan 17
Corvus Pharmaceuticals Names Ian T. Clark, Former Genentech Chief Executive Officer, to Board of Directors
12:00am
8-K
mczj5ovzz5l
8 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
bs3hu 4tkc
14 Nov 16
Other Events
12:00am
8-K
fwbu1y oxvj64x5
3 Nov 16
Corvus Pharmaceuticals Announces Third Quarter Financial Results
12:00am
8-K
ggvn uuku2wtihf63qek
11 Oct 16
Corvus Pharmaceuticals Announces Biomarker Findings from
12:00am
8-K
ffeox8
26 Sep 16
International Cancer Immunotherapy Conference
12:00am
8-K
m2yjl9xof 930yu
4 Aug 16
Corvus Pharmaceuticals Announces Second Quarter Financial Results
12:00am
8-K
1m5 dt769g
5 May 16
Corvus Pharmaceuticals Announces First Quarter 2016 Financial Results
12:00am
10-Q
j6pwuhulr0ownkhd5
5 May 16
Quarterly report
12:00am
8-K
6rs 7z51psp38z6z
20 Apr 16
Other Events
12:00am
8-K
z42ks
29 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
S-8
tsps tlbckebejzzwdpr
29 Mar 16
Registration of securities for employees
12:00am
CT ORDER
n4pot4bco9cdf9czu07w
25 Mar 16
Confidential treatment order
12:00am
424B4
mwq5eg4
24 Mar 16
Prospectus supplement with pricing info
12:00am
EFFECT
zvjqrrsjpl6psg
22 Mar 16
Notice of effectiveness
12:00am
CORRESP
7nnh5k3g4vbu 8tzjifx
18 Mar 16
Correspondence with SEC
12:00am
CORRESP
iwfe6vsi5q5yk1qgp
18 Mar 16
Correspondence with SEC
12:00am
8-A12B
8rrlt4wxl3i31 r2
16 Mar 16
Registration of securities on exchange
12:00am